Literature DB >> 29312975

Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history.

Danny Issa1, Naim Alkhouri2,3.   

Abstract

Entities:  

Year:  2017        PMID： 29312975      PMCID： PMC5756767          DOI： 10.21037/hbsn.2017.07.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  19 in total

1.  Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.

Authors:  Christopher Leung; Sern Wei Yeoh; Desmond Patrick; Shara Ket; Kaye Marion; Paul Gow; Peter W Angus
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

2.  Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort.

Authors:  Sabrina Schlesinger; Krasimira Aleksandrova; Tobias Pischon; Veronika Fedirko; Mazda Jenab; Elisabeth Trepo; Paolo Boffetta; Christina C Dahm; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Franck Carbonnel; Rudolf Kaaks; Annekatrin Lukanova; Heiner Boeing; Antonia Trichopoulou; Christina Bamia; Pagona Lagiou; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-de-Mesquita; Saskia van den Berg; Petra H M Peeters; Tonje Braaten; Elisabete Weiderpass; J Ramón Quirós; Noémie Travier; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Miren Dorronsoro; Björn Lindkvist; Sara Regner; Mårten Werner; Malin Sund; Kay-Tee Khaw; Nicholas Wareham; Ruth C Travis; Teresa Norat; Petra A Wark; Elio Riboli; Ute Nöthlings
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

3.  Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.

Authors:  Hesam Tavakoli; Ann Robinson; Benny Liu; Taft Bhuket; Zobair Younossi; Sammy Saab; Aijaz Ahmed; Robert J Wong
Journal:  Dig Dis Sci       Date:  2017-05-04       Impact factor: 3.199

4.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  O Simmons; D T Fetzer; T Yokoo; J A Marrero; A Yopp; Y Kono; N D Parikh; T Browning; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2016-11-08       Impact factor: 8.171

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 6.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

Review 7.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

8.  Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Authors:  Manlio Vinciguerra; Fabio Carrozzino; Marion Peyrou; Sebastiano Carlone; Roberto Montesano; Roberto Benelli; Michelangelo Foti
Journal:  J Hepatol       Date:  2009-04-01       Impact factor: 25.083

9.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Rachel M Williamson; Jackie F Price; Stephen Glancy; Elisa Perry; Lisa D Nee; Peter C Hayes; Brian M Frier; Liesbeth A F Van Look; Geoffrey I Johnston; Rebecca M Reynolds; Mark W J Strachan
Journal:  Diabetes Care       Date:  2011-04-08       Impact factor: 19.112
View more
  7 in total

1.  MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.

Authors:  Tianpeng Zhang; Junjie Hu; Xiaomei Wang; Xiaoling Zhao; Zhuoyu Li; Junqi Niu; Clifford J Steer; Guohua Zheng; Guisheng Song
Journal:  J Hepatol       Date:  2018-09-13       Impact factor: 25.083

Review 2.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

3.  Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Hao Chiang; Hsu-Feng Lu; Jui-Chieh Chen; Yu-Hsin Chen; Hsi-Tai Sun; Hsiu-Chen Huang; Hsiao-Hsuan Tien; Cheng Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-29       Impact factor: 2.629

4.  A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.

Authors:  Feifei Guo; Olga Estévez-Vázquez; Raquel Benedé-Ubieto; Douglas Maya-Miles; Kang Zheng; Rocío Gallego-Durán; Ángela Rojas; Javier Ampuero; Manuel Romero-Gómez; Kaye Philip; Isioma U Egbuniwe; Chaobo Chen; Jorge Simon; Teresa C Delgado; María Luz Martínez-Chantar; Jie Sun; Johanna Reissing; Tony Bruns; Arantza Lamas-Paz; Manuel Gómez Del Moral; Marius Maximilian Woitok; Javier Vaquero; José R Regueiro; Christian Liedtke; Christian Trautwein; Rafael Bañares; Francisco Javier Cubero; Yulia A Nevzorova
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

5.  Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.

Authors:  Xianwen Yuan; Jun Chen; Qi Cheng; Yinjuan Zhao; Pengzi Zhang; Xiaoyan Shao; Yan Bi; Xiaolei Shi; Yitao Ding; Xitai Sun; Bin Xue
Journal:  BMC Gastroenterol       Date:  2018-10-03       Impact factor: 3.067

6.  Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.

Authors:  Annette Brandt; Anika Nier; Cheng Jun Jin; Anja Baumann; Finn Jung; Vicent Ribas; Carmen García-Ruiz; Jose C Fernández-Checa; Ina Bergheim
Journal:  Redox Biol       Date:  2018-12-23       Impact factor: 11.799

7.  Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain.

Authors:  Manuel Romero-Gomez; Nandita Kachru; Meritxell Ascanio Zamorano; Josep Darba; Sanatan Shreay
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.